Welcome to our dedicated page for Nature's Miracle Holding SEC filings (Ticker: NMHIW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Nature's Miracle Holding's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Nature's Miracle Holding's regulatory disclosures and financial reporting.
Nature’s Miracle Holding Inc. filed its annual report describing a controlled-environment agriculture hardware business that remains unprofitable and under significant financial strain. The company generated approximately $9.3 million of revenue in 2024 with a gross loss of $2.8 million, and reports recurring operating losses and negative operating cash flow that raise substantial doubt about its ability to continue as a going concern.
Management notes a sharp revenue concentration, with the top five customers providing 56.30% of 2025 revenue of $1,742,360, and major dependence on a handful of suppliers that represented over 90% of 2024 and 2025 purchases. In 2025, the company diversified by acquiring the PNC Bank Tower in Toledo, Ohio, assuming $2.65 million of loans and issuing a new $3 million secured note, and expects $1.8–$2.0 million in annual gross rents starting 2026.
The report highlights past equity raises in 2024 largely used to repay merger-related and short-term debt, additional 2025 financing through convertible debt and preferred equity, and settlements involving merchant cash advance lenders. Nature’s Miracle also discloses that its shares were delisted from Nasdaq in January 2025 for not meeting minimum shareholders’ equity requirements and now trade on the OTC Pink Market.
Nature’s Miracle Holding Inc. filed its annual report describing a controlled-environment agriculture hardware business that remains unprofitable and under significant financial strain. The company generated approximately $9.3 million of revenue in 2024 with a gross loss of $2.8 million, and reports recurring operating losses and negative operating cash flow that raise substantial doubt about its ability to continue as a going concern.
Management notes a sharp revenue concentration, with the top five customers providing 56.30% of 2025 revenue of $1,742,360, and major dependence on a handful of suppliers that represented over 90% of 2024 and 2025 purchases. In 2025, the company diversified by acquiring the PNC Bank Tower in Toledo, Ohio, assuming $2.65 million of loans and issuing a new $3 million secured note, and expects $1.8–$2.0 million in annual gross rents starting 2026.
The report highlights past equity raises in 2024 largely used to repay merger-related and short-term debt, additional 2025 financing through convertible debt and preferred equity, and settlements involving merchant cash advance lenders. Nature’s Miracle also discloses that its shares were delisted from Nasdaq in January 2025 for not meeting minimum shareholders’ equity requirements and now trade on the OTC Pink Market.
Nature’s Miracle Holding Inc. filed an amended quarterly report to restate its unaudited financial statements for the three and nine months ended September 30, 2025 after identifying an unrecorded $1.65 million short‑term loan at newly acquired Zak Properties.
The restatement increases short‑term loans and total liabilities and reduces additional paid‑in capital, deepening the stockholders’ deficit to $(9.36) million. For the nine months, the company generated revenue of $1.66 million and recorded a net loss of $5.99 million, with cash of only $61,450 and a working capital deficit of about $19.7 million.
Management concludes that recurring losses, negative operating cash flow and large deficits raise substantial doubt about Nature’s Miracle’s ability to continue as a going concern. The company cites material weaknesses in internal control over financial reporting, particularly around due diligence for acquisitions, and plans enhanced reconciliation and review controls.
Nature’s Miracle Holding Inc. filed an amended quarterly report to restate its unaudited financial statements for the three and nine months ended September 30, 2025 after identifying an unrecorded $1.65 million short‑term loan at newly acquired Zak Properties.
The restatement increases short‑term loans and total liabilities and reduces additional paid‑in capital, deepening the stockholders’ deficit to $(9.36) million. For the nine months, the company generated revenue of $1.66 million and recorded a net loss of $5.99 million, with cash of only $61,450 and a working capital deficit of about $19.7 million.
Management concludes that recurring losses, negative operating cash flow and large deficits raise substantial doubt about Nature’s Miracle’s ability to continue as a going concern. The company cites material weaknesses in internal control over financial reporting, particularly around due diligence for acquisitions, and plans enhanced reconciliation and review controls.
Nature’s Miracle Holding Inc. announced that investors should no longer rely on its previously issued unaudited condensed consolidated financial statements as of and for the period ended September 30, 2025. Those statements, filed on Form 10-Q on November 14, 2025, omitted an amount in short term loans.
The company has restated its condensed financial statements for the three and nine months ended September 30, 2025 to properly record the short term loan and will file an amended Form 10-Q/A for that quarter. Management and the Audit Committee discussed these matters with the company’s independent registered public accounting firm and with WWC, P.C., its auditor for the fiscal year ended December 31, 2025.
Nature’s Miracle Holding Inc. announced that investors should no longer rely on its previously issued unaudited condensed consolidated financial statements as of and for the period ended September 30, 2025. Those statements, filed on Form 10-Q on November 14, 2025, omitted an amount in short term loans.
The company has restated its condensed financial statements for the three and nine months ended September 30, 2025 to properly record the short term loan and will file an amended Form 10-Q/A for that quarter. Management and the Audit Committee discussed these matters with the company’s independent registered public accounting firm and with WWC, P.C., its auditor for the fiscal year ended December 31, 2025.
Nature’s Miracle Holding Inc. (NMHI) has amended its charter to sharply increase its authorized common stock. The company filed a Certificate of Amendment in Delaware to raise its authorized common stock, par value $0.0001 per share, from 100,000,000 shares to 1,000,000,000 shares.
This change was approved by written consent of shareholders holding a majority of the voting power of the outstanding common and preferred stock, following a recommendation by the Board of Directors. The higher authorization does not by itself issue new shares, but it allows the company to issue additional equity in the future for purposes such as financings, acquisitions or equity incentives if it chooses to do so.
Nature’s Miracle Holding Inc. (NMHI) has amended its charter to sharply increase its authorized common stock. The company filed a Certificate of Amendment in Delaware to raise its authorized common stock, par value $0.0001 per share, from 100,000,000 shares to 1,000,000,000 shares.
This change was approved by written consent of shareholders holding a majority of the voting power of the outstanding common and preferred stock, following a recommendation by the Board of Directors. The higher authorization does not by itself issue new shares, but it allows the company to issue additional equity in the future for purposes such as financings, acquisitions or equity incentives if it chooses to do so.
Nature’s Miracle Holding Inc. (NMHI) reported that shareholders holding approximately 98.6% of voting power approved by written consent two actions: authorizing the Board to implement a reverse stock split at a ratio between 1:5 and 1:20, and amending the Certificate of Incorporation to increase authorized common shares from 100,000,000 to 1,000,000,000.
The reverse split, if effected after the required 20-day notice period, would reduce outstanding shares proportionally; for example, at 1:10, outstanding common would move from 13,955,251 to 1,395,525 shares. Fractional shares will be rounded down to the next whole share. The Board may choose any whole-number ratio within the approved range or abandon the split at its discretion.
The company states the primary purposes are to support potential exchange listing requirements, broaden investor access, and provide flexibility for financings. The authorized share increase is intended in part to facilitate an equity line with GHS Investments for up to 55,817,669 shares under a $20,000,000 facility, as well as other potential corporate uses. No appraisal rights are available.
Nature’s Miracle Holding Inc. (NMHI) reported that shareholders holding approximately 98.6% of voting power approved by written consent two actions: authorizing the Board to implement a reverse stock split at a ratio between 1:5 and 1:20, and amending the Certificate of Incorporation to increase authorized common shares from 100,000,000 to 1,000,000,000.
The reverse split, if effected after the required 20-day notice period, would reduce outstanding shares proportionally; for example, at 1:10, outstanding common would move from 13,955,251 to 1,395,525 shares. Fractional shares will be rounded down to the next whole share. The Board may choose any whole-number ratio within the approved range or abandon the split at its discretion.
The company states the primary purposes are to support potential exchange listing requirements, broaden investor access, and provide flexibility for financings. The authorized share increase is intended in part to facilitate an equity line with GHS Investments for up to 55,817,669 shares under a $20,000,000 facility, as well as other potential corporate uses. No appraisal rights are available.